Leiters
Leiters Health, founded in 1926, is an FDA-registered 503B outsourcing provider offering high-quality compounded sterile preparations for hospitals and ophthalmology, with a state-of-the-art facility in Denver, Colorado.
History
Leiters Health was founded in 1926. Over the decades, it has grown into a significant player in the healthcare industry, specializing in high-quality hospital and ophthalmic compounded sterile preparations. The company is now an FDA-registered 503B outsourcing provider, committed to adhering to all necessary compliance and regulations.
Products
Leiters Health provides a comprehensive portfolio of products, including high-quality ready-to-use hospital and ophthalmology compounded sterile preparations. The products offered include repackaged Avastin®, pre-filled syringes, vials, bags, concentrated vials, and IV solutions. These are designed to support various medical needs, including pain management throughout the surgical journey, and are compliant with stringent FDA regulations.
Services
Leiters Health offers a variety of 503B services, including hospital services, ophthalmics, pain services, and IV solutions. They also provide the Pharmacy Fill Service for the Avanos ON-Q* Pain Relief System. Their services are supported by a state-of-the-art outsourcing facility in Denver, Colorado, which is FDA-registered and cGMP compliant.
Facility
Leiters Health's state-of-the-art outsourcing facility is located in Denver, Colorado. This facility is FDA-registered and cGMP compliant, ensuring high standards of quality and safety. It has been inspected and accredited by multiple entities, including the FDA, State of California Board of Pharmacy, and various health systems and group purchasing organizations.
Sector
Leiters Health operates in the healthcare sector, focusing on the production and distribution of high-quality compounded sterile preparations for hospitals and ophthalmic use. The company's offerings are integral to pain management, enhanced surgical recovery strategies, and the treatment of retinal diseases, highlighting their role in specialized healthcare solutions.